Favipiravir – Concept to commercialisation in less than 2 months, we have commercialized Favipiravir API suitable for global market
Favipiravir is the generic version of Avigan. The drug has demonstrated positive outcomes, including a reduction in the duration of Covid-19 and improved lung conditions for the patients.
Aurore Lifesciences is the first Indian API manufactured to have commercialized the Favipiravir API for global market.
We offer this API from our Unit 1 site with quality accreditations and compliances. We have the API ready with completed documentation as per ICH and supply chain control established.